Smart119
Enhancing emergency and critical care through AI-driven innovation.
Enhancing emergency and critical care through AI-driven innovation.
Smart119 is a promising healthcare startup founded in 2018, with a clear goal of enhancing emergency and critical care using cutting-edge technologies. The company, led by the Professor and Chairman of National Chiba University Graduate School of Medicine, Department of Emergency and Critical Care Medicine, is focused on leveraging computer science and artificial intelligence to drive innovations in the medical field. In a significant milestone, the company secured a ¥306.75M Series B investment on 10th August 2021, with notable participation from Nissay Capital, Pksha Capital, Sony Innovation Fund, MITSUI SUMITOMO INSURANCE Venture Capital (MSIVC), and SPARX AI & Technologies Investment. Smart119's commitment to leveraging technology for transformative healthcare solutions makes it an attractive prospect for potential investors seeking opportunities in the evolving healthcare landscape.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Series B | ¥306.75M | 5 |
-logo.jpg){kind=logo}
|
10 Aug 2021 |
| Series A | ¥91.00M | 3 |
|
23 Aug 2019 |
No recent news or press coverage available for Smart119.
We care about your data, and we'd love to use cookies make your experience better.
